University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death.

dc.contributor.authorWoodley, Keith
dc.contributor.authorDillingh, LS
dc.contributor.authorGiotopoulos, George
dc.contributor.authorMadrigal, Pedro
dc.contributor.authorRattigan, KM
dc.contributor.authorPhilippe, Céline
dc.contributor.authorDembitz, Vilma
dc.contributor.authorMagee, AMS
dc.contributor.authorAsby, R
dc.contributor.authorvan de Lagemaat, Louie N
dc.contributor.authorMapperley, Christopher
dc.contributor.authorJames, SC
dc.contributor.authorPrehn, JHM
dc.contributor.authorTzelepis, Konstantinos
dc.contributor.authorRouault-Pierre, Kevin
dc.contributor.authorVassiliou, George
dc.contributor.authorKranc, Kamil
dc.contributor.authorHelgason, G Vignir
dc.contributor.authorHuntly, BJP
dc.contributor.authorGallipoli, Paolo
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.date.accessioned2023-09-14T10:37:00Z
dc.date.available2023-09-14T10:37:00Z
dc.date.issued2023-04-14
dc.descriptionAcknowledgements We wish to thank the Barts Cancer Institute tissue bank for sample collection and processing. This research was supported by the BCI Flow cytometry facility (CRUK Core Award C16420/A18066). This work was supported by the Wellcome Trust (PG, 109967/Z/15/Z), the American Society of Haematology (PG, Global Research Award) and Cancer Research UK (PG, Advanced Clinician Scientist fellowship, C57799/A27964). K.R-P. was supported by the Academy of Medical Sciences (SBF004\1099) J.H.M.P. was supported by a research grant from Science Foundation Ireland (SFI) under Grant Number 16/RC/3948 and co-funded under the European Regional Development Fund and by FutureNeuro industry partners. K.T. was funded by Wellcome Trust (Grant References: RG94424, RG83195, G106133), UKRI Medical Research Council (RG83195) and Leukaemia UK (G108148).en
dc.description.statusPeer revieweden
dc.format.extent19
dc.format.extent1565762
dc.identifier272251574
dc.identifier62dea054-7347-4465-abce-c8ba45072461
dc.identifier37059720
dc.identifierPMC10104861
dc.identifier85152580097
dc.identifier.citationWoodley, K, Dillingh, LS, Giotopoulos, G, Madrigal, P, Rattigan, KM, Philippe, C, Dembitz, V, Magee, AMS, Asby, R, van de Lagemaat, L N, Mapperley, C, James, SC, Prehn, JHM, Tzelepis, K, Rouault-Pierre, K, Vassiliou, G, Kranc, K, Helgason, G V, Huntly, BJP & Gallipoli, P 2023, 'Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death.', Nature Communications, vol. 14, 2132. https://doi.org/10.1038/s41467-023-37652-0en
dc.identifier.doi10.1038/s41467-023-37652-0
dc.identifier.issn2041-1723
dc.identifier.otherORCID: /0000-0002-2947-1557/work/140168203
dc.identifier.urihttps://hdl.handle.net/2164/21669
dc.identifier.urlhttps://europepmc.org/articles/PMC10104861en
dc.identifier.vol14en
dc.language.isoeng
dc.relation.ispartofNature Communicationsen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectcancer metabolismen
dc.subjectcancer therapeutic resistanceen
dc.subjectR Medicineen
dc.subjectWellcome Trusten
dc.subjectPG, 109967/Z/15/Zen
dc.subjectRG94424en
dc.subjectRG83195en
dc.subjectCancer Research UKen
dc.subjectC16420/A18066en
dc.subjectC57799/A27964en
dc.subjectG106133en
dc.subjectMedical Research Council (MRC)en
dc.subjectRG83195en
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleMannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death.en
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
He_etal_CMC_Fine-Grained_Multivariate_Time_VOR.pdf
Size:
1.49 MB
Format:
Adobe Portable Document Format

Collections